MedPath

Sernova Corp

Sernova Corp logo
🇨🇦Canada
Ownership
-
Employees
3K
Market Cap
-
Website
Introduction

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Phase 1
Recruiting
Conditions
Type 1 Diabetes Mellitus
First Posted Date
2018-05-02
Last Posted Date
2025-01-08
Lead Sponsor
Sernova Corp
Target Recruit Count
17
Registration Number
NCT03513939
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.